Literature DB >> 9788967

Exposure to bacterial products renders macrophages highly susceptible to T-tropic HIV-1.

M Moriuchi1, H Moriuchi, W Turner, A S Fauci.   

Abstract

Microbial coinfections variably influence HIV-1 infection through immune activation or direct interaction of microorganisms with HIV-1 or its target cells. In this study, we investigated whether exposure of macrophages to bacterial products impacts the susceptibility of these cells to HIV-1 of different cellular tropisms. We demonstrate that () macrophages exposed to bacterial cell wall components such as lipopolysaccharide (LPS) (Gram-negative rods), lipoteichoic acid (Gram-positive cocci), and lipoarabinomannan (Mycobacteria) become highly susceptible to T cell (T)-tropic HIV-1 (which otherwise poorly replicate in macrophages) and variably susceptible to macrophage (M)-tropic HIV-1; () LPS-stimulated macrophages secrete a number of soluble factors (i.e., chemokines, interferon, and proinflammatory cytokines) that variably affect HIV infection of macrophages, depending on the virus phenotype in question; and () LPS-stimulated macrophages express CCR5 (a major coreceptor for M-tropic HIV-1) at lower levels and CXCR4 (a major coreceptor for T-tropic HIV-1) at higher levels compared with unstimulated macrophages. We hypothesize that a more favorable environment for T-tropic HIV-1 and a less favorable or even unfavorable environment for M-tropic HIV-1 secondary to exposure of macrophages to those bacterial products may accerelate a transition from M- to T-tropic viral phenotype, which is indicative of disease progression.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9788967      PMCID: PMC509004          DOI: 10.1172/JCI4151

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  78 in total

1.  HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5.

Authors:  T Dragic; V Litwin; G P Allaway; S R Martin; Y Huang; K A Nagashima; C Cayanan; P J Maddon; R A Koup; J P Moore; W A Paxton
Journal:  Nature       Date:  1996-06-20       Impact factor: 49.962

2.  The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates.

Authors:  H Choe; M Farzan; Y Sun; N Sullivan; B Rollins; P D Ponath; L Wu; C R Mackay; G LaRosa; W Newman; N Gerard; C Gerard; J Sodroski
Journal:  Cell       Date:  1996-06-28       Impact factor: 41.582

3.  Cloning and analysis of the promoter region of CCR5, a coreceptor for HIV-1 entry.

Authors:  H Moriuchi; M Moriuchi; A S Fauci
Journal:  J Immunol       Date:  1997-12-01       Impact factor: 5.422

Review 4.  Altered cell signaling and mononuclear phagocyte deactivation during intracellular infection.

Authors:  N E Reiner
Journal:  Immunol Today       Date:  1994-08

5.  The biological phenotype of HIV-1 is usually retained during and after sexual transmission.

Authors:  J R Fiore; A Björndal; K A Peipke; M Di Stefano; G Angarano; G Pastore; H Gaines; E M Fenyö; J Albert
Journal:  Virology       Date:  1994-10       Impact factor: 3.616

6.  HIV-1 macrophage tropism is determined at multiple levels of the viral replication cycle.

Authors:  R A Fouchier; M Brouwer; N A Kootstra; H G Huisman; H Schuitemaker
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

7.  Macrophage-tropic variants initiate human immunodeficiency virus type 1 infection after sexual, parenteral, and vertical transmission.

Authors:  A B van't Wout; N A Kootstra; G A Mulder-Kampinga; N Albrecht-van Lent; H J Scherpbier; J Veenstra; K Boer; R A Coutinho; F Miedema; H Schuitemaker
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

8.  Human immunodeficiency virus type 1 T-lymphotropic strains enter macrophages via a CD4- and CXCR4-mediated pathway: replication is restricted at a postentry level.

Authors:  H Schmidtmayerova; M Alfano; G Nuovo; M Bukrinsky
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

9.  Infection of human immunodeficiency virus 1 transgenic mice with Toxoplasma gondii stimulates proviral transcription in macrophages in vivo.

Authors:  R T Gazzinelli; A Sher; A Cheever; S Gerstberger; M A Martin; P Dickie
Journal:  J Exp Med       Date:  1996-04-01       Impact factor: 14.307

10.  Factors secreted by human T lymphotropic virus type I (HTLV-I)-infected cells can enhance or inhibit replication of HIV-1 in HTLV-I-uninfected cells: implications for in vivo coinfection with HTLV-I and HIV-1.

Authors:  H Moriuchi; M Moriuchi; A S Fauci
Journal:  J Exp Med       Date:  1998-05-18       Impact factor: 14.307

View more
  19 in total

1.  Proline-proline-glutamic acid (PPE) protein Rv1168c of Mycobacterium tuberculosis augments transcription from HIV-1 long terminal repeat promoter.

Authors:  Khalid Hussain Bhat; Chinta Krishna Chaitanya; Nazia Parveen; Raja Varman; Sudip Ghosh; Sangita Mukhopadhyay
Journal:  J Biol Chem       Date:  2012-03-15       Impact factor: 5.157

2.  S100A14 Is Increased in Activated NK Cells and Plasma of HIV-Exposed Seronegative People Who Inject Drugs and Promotes Monocyte-NK Crosstalk.

Authors:  Krystal Colón; David W Speicher; Peter Smith; Mack Taylor; David S Metzger; Luis J Montaner; Costin Tomescu
Journal:  J Acquir Immune Defic Syndr       Date:  2019-02-01       Impact factor: 3.731

Review 3.  Humoral immune responses to Streptococcus pneumoniae in the setting of HIV-1 infection.

Authors:  Lumin Zhang; Zihai Li; Zhuang Wan; Andrew Kilby; J Michael Kilby; Wei Jiang
Journal:  Vaccine       Date:  2015-06-30       Impact factor: 3.641

4.  Bacterial lipopolysaccharide enhances cardiac dysfunction but not retroviral replication in murine AIDS: roles of macrophage infiltration and toll-like receptor 4 expression.

Authors:  Alysia A Chaves; Reshma S Baliga; Michael J Mihm; Brandon L Schanbacher; Anupam Basuray; Cynthia Liu; Angela C Cook; Leona W Ayers; John Anthony Bauer
Journal:  Am J Pathol       Date:  2006-03       Impact factor: 4.307

5.  Neisseria gonorrhoeae enhances HIV-1 infection of primary resting CD4+ T cells through TLR2 activation.

Authors:  Jian Ding; Aprille Rapista; Natalia Teleshova; Goar Mosoyan; Gary A Jarvis; Mary E Klotman; Theresa L Chang
Journal:  J Immunol       Date:  2010-02-10       Impact factor: 5.422

6.  Human immunodeficiency virus type 1 (HIV-1)-induced GRO-alpha production stimulates HIV-1 replication in macrophages and T lymphocytes.

Authors:  B R Lane; R M Strieter; M J Coffey; D M Markovitz
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

7.  Coreceptor competition for association with CD4 may change the susceptibility of human cells to infection with T-tropic and macrophagetropic isolates of human immunodeficiency virus type 1.

Authors:  S Lee; C K Lapham; H Chen; L King; J Manischewitz; T Romantseva; H Mostowski; T S Stantchev; C C Broder; H Golding
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

8.  Mutagenesis of CXCR4 identifies important domains for human immunodeficiency virus type 1 X4 isolate envelope-mediated membrane fusion and virus entry and reveals cryptic coreceptor activity for R5 isolates.

Authors:  D J Chabot; P F Zhang; G V Quinnan; C C Broder
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

9.  Cathepsin G, a neutrophil-derived serine protease, increases susceptibility of macrophages to acute human immunodeficiency virus type 1 infection.

Authors:  H Moriuchi; M Moriuchi; A S Fauci
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

10.  Human peritoneal macrophages from ascitic fluid can be infected by a broad range of HIV-1 isolates.

Authors:  Theresa L Chang; Arielle Klepper; Jian Ding; John Garber; Aprille Rapista; Arevik Mosoian; Wolfgang Hubner; Julio Gutierrez; Jose Walewski; Jeffrey Abergel; Thomas Schiano; Andrea Branch
Journal:  J Acquir Immune Defic Syndr       Date:  2010-03       Impact factor: 3.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.